Crossmark

Examiners’ influence on the measured active and passive extension deficit in finger joints affected by Dupuytren disease

Crossref DOI link: https://doi.org/10.1186/s12874-018-0577-8

Published Online: 2018-10-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nordenskjöld, Jesper https://orcid.org/0000-0002-8049-5263
Brodén, Stina

Atroshi, Isam
License Information

Text and Data Mining valid from 2018-10-29
More Information

Article History

Received: 22 October 2017

Accepted: 16 October 2018

First Online: 29 October 2018

Ethics approval and consent to participate

: The Regional Ethical Review Board in Lund, Sweden, waived the need for ethics approval (DNR 2013/656). The study was conducted in accordance with the Helsinki Declaration of 1975 as revised in 2000. An oral and written consent to participate was obtained from all patients.

: The patient in Fig. provided oral and written consent for publication.

: IA was a member of an expert group on Dupuytren disease for Pfizer in 2012 and participated in meetings organized by Sobi. JN and SB have no competing interests to declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.